New Study Enrolling: RISE - Treating Ulcerative Colitis

AdventHealth Research Institute is the first in Central Florida to participate in the expansion phase of a clinical trial exploring a potential new oral immunotherapy treatment for mild to moderate ulcerative colitis. Called RISE-3750-01 and led by AdventHealth IBD Clinic Medical Director Jennifer Seminerio, MD, the study is evaluating the safety and tolerability of R-3750, which was designed to enhance the gut barrier, reduce inflammation and correct imbalance in the microbiota. Click below to learn more about this exciting study.

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

Understanding Hypoglycemia and the CLEAR Study

The CLEAR Study is a groundbreaking, international research effort funded by the NIH that aims to help people with Type 1 diabetes (T1D) who can no longer sense when their blood sugar is dangerously...

News

Did you know? Women, Hormones, and Heart Risk

Heart disease is often thought of as a “man’s disease,” but it remains the leading cause of death for women in the United States. We asked Katie Love, MD, MSc, an investigator at the AdventHealth...